aceclofenac has been researched along with Adverse Drug Event in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Abd El-Aty, AM; Bang, JS; Chung, YH; Jeong, JC; Jeong, JH; Jung, TW; Park, SY; Park, T | 1 |
| Castell, JV; Donato, MT; Gómez-Lechón, MJ | 1 |
| de Kanter, R; Hewitt, NJ; LeCluyse, E | 1 |
2 review(s) available for aceclofenac and Adverse Drug Event
| Article | Year |
|---|---|
Hepatocytes--the choice to investigate drug metabolism and toxicity in man: in vitro variability as a reflection of in vivo.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Biotransformation; Cells, Cultured; Cytochrome P-450 Enzyme System; Diclofenac; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Genetic Variation; Hepatocytes; Humans; In Vitro Techniques; Inactivation, Metabolic; Metabolic Networks and Pathways; Models, Biological; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics | 2007 |
Induction of drug metabolizing enzymes: a survey of in vitro methodologies and interpretations used in the pharmaceutical industry--do they comply with FDA recommendations?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cell Culture Techniques; Cells, Cultured; Data Collection; Data Interpretation, Statistical; Diclofenac; Drug Industry; Drug-Related Side Effects and Adverse Reactions; Enzyme Induction; Enzymes; Guideline Adherence; Health Planning Guidelines; Humans; Molecular Structure; Pharmaceutical Preparations; United States; United States Food and Drug Administration | 2007 |
2 other study(ies) available for aceclofenac and Adverse Drug Event
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Safety and effectiveness of 4-week therapy with aceclofenac controlled release once a day.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Delayed-Action Preparations; Diclofenac; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Tablets; Treatment Outcome | 2022 |